...
首页> 外文期刊>Cancer Management and Research >Role of the pretreatment neutrophil-to-lymphocyte ratio in the survival of primary parotid cancer patients
【24h】

Role of the pretreatment neutrophil-to-lymphocyte ratio in the survival of primary parotid cancer patients

机译:预处理中性白细胞与淋巴细胞比例在原发腮腺癌患者生存中的作用

获取原文
           

摘要

Background: To analyze the value of the pretreatment neutrophil-to-lymphocyte ratio (NLR) in the survival of patients with parotid cancer. Methods: In total, 249 patients were enrolled. Information including age, sex, pretreatment NLR, and pathologic variables such as, tumor stage, intraparotid node (IPN) metastasis, and follow-up findings was extracted and analyzed. Results: IPN metastasis was noted in 45 (18.1%) patients, and the mean NLR was 2.48, with a range from 1.5 to 6.1. The NLR was significantly associated with tumor stage, disease stage, and disease grade. A total of 73 patients died of the disease, and the 10 -year disease-specific survival (DSS) rate was 62%. In patients with an NLR2.48, the 10 -year DSS rate was 68%; in patients with an NLR≥2.48, the 10 -year DSS rate was 58%, and the difference was significant ( P =0.006). Cox model analysis showed that the NLR was an independent prognostic factor for DSS. Conclusion: The long-term survival of primary parotid cancer patients is relatively favorable, and the pretreatment NLR is significantly associated with prognosis.
机译:背景:分析预处理中性粒细胞与淋巴细胞之比(NLR)在腮腺癌患者生存中的价值。方法:共有249例患者入选。提取并分析了包括年龄,性别,治疗前NLR以及病理变量(例如肿瘤分期,腮腺内结节(IPN)转移)和随访结果在内的信息。结果:在45例患者中发现IPN转移(18.1%),平均NLR为2.48,范围为1.5至6.1。 NLR与肿瘤分期,疾病分期和疾病等级显着相关。共有73例患者死于该病,十年疾病特异性存活率(DSS)为62%。 NLR <2.48的患者的10年DSS率为68%;在NLR≥2.48的患者中,十年期DSS率为58%,差异有统计学意义(P = 0.006)。 Cox模型分析表明,NLR是DSS的独立预后因素。结论:原发性腮腺癌患者的长期生存相对较好,且治疗前的NLR与预后密切相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号